Abstract
OBJECTIVE: To examine antenatal screening as a predictor of intrapartum shedding of herpes simplex virus (HSV) and to determine its usefulness in guiding the appropriate route of delivery for patients with recurrent HSV in pregnancy. METHODS: A population of 198 pregnant women with a history of recurrent genital HSV were cultured in the last weeks of their pregnancy by specially-trained personnel and intrapartum by their delivering attendants. RESULTS: Of cultures from a total of 906 antenatal visits, 17% were culture positive, with an asymptomatic shedding rate of 3.4%. Asymptomatic shedding occurred in 12.6% of women. Over the 8-week antepartum period, viral culture-positivity rates for each visit ranged from 11% to 19.5%. This provided an expected delivery culture-positivity rate of 15.3%. However, actual intrapartum viral culture positivity occurred in only three of 191 women (1.5%; P < 0.001). Because previous studies have suggested antepartum culture positivity fails to predict intrapartum viral shedding, evaluations, including cultures, as well as predictive values for subsequent culture positivities, were determined under the supervision of an infectious disease specialist. Under these conditions, positive predictive values were 59% when the interval between visits was 2 days, but only 19% when days between visits were >2 (P < 0.0001). No cases of neonatal herpes were seen in this population, although cesarean deliveries were performed in 31% of the patient population, with genital herpes as the indication for 56% of those. CONCLUSIONS: Antepartum serial screening by viral culture is not predictive of an infant's risk of intrapartum viral exposure when conducted at weekly intervals. However, more frequent assessments of patients can be predictive of an infant's exposure risk to HSV; for patients with frequent recurrent disease near term or primary infection in pregnancy, frequent late antepartum screening may be appropriate.
Full Text
The Full Text of this article is available as a PDF (619.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arvin A. M., Hensleigh P. A., Prober C. G., Au D. S., Yasukawa L. L., Wittek A. E., Palumbo P. E., Paryani S. G., Yeager A. S. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med. 1986 Sep 25;315(13):796–800. doi: 10.1056/NEJM198609253151303. [DOI] [PubMed] [Google Scholar]
- Brown Z. A., Benedetti J., Ashley R., Burchett S., Selke S., Berry S., Vontver L. A., Corey L. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med. 1991 May 2;324(18):1247–1252. doi: 10.1056/NEJM199105023241804. [DOI] [PubMed] [Google Scholar]
- Brown Z. A., Selke S., Zeh J., Kopelman J., Maslow A., Ashley R. L., Watts D. H., Berry S., Herd M., Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997 Aug 21;337(8):509–515. doi: 10.1056/NEJM199708213370801. [DOI] [PubMed] [Google Scholar]
- Brown Z. A., Vontver L. A., Benedetti J., Critchlow C. W., Sells C. J., Berry S., Corey L. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med. 1987 Nov 12;317(20):1246–1251. doi: 10.1056/NEJM198711123172002. [DOI] [PubMed] [Google Scholar]
- Catalano P. M., Merritt A. O., Mead P. B. Incidence of genital herpes simplex virus at the time of delivery in women with known risk factors. Am J Obstet Gynecol. 1991 May;164(5 Pt 1):1303–1306. doi: 10.1016/0002-9378(91)90704-u. [DOI] [PubMed] [Google Scholar]
- Chuang T. Y. Neonatal herpes: incidence, prevention, and consequences. Am J Prev Med. 1988 Jan-Feb;4(1):47–53. [PubMed] [Google Scholar]
- Frenkel L. M., Brown Z. A., Bryson Y. J., Corey L., Unadkat J. D., Hensleigh P. A., Arvin A. M., Prober C. G., Connor J. D. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol. 1991 Feb;164(2):569–576. doi: 10.1016/s0002-9378(11)80023-2. [DOI] [PubMed] [Google Scholar]
- Garland S. M., Lee T. N., Ashley R. L., Corey L., Sacks S. L. Automated microneutralization: method and comparison with western blot for type-specific detection of herpes simplex antibodies in two pregnant populations. J Virol Methods. 1995 Nov;55(3):285–294. doi: 10.1016/0166-0934(95)00061-9. [DOI] [PubMed] [Google Scholar]
- Garland S. M. Neonatal herpes simplex: Royal Women's Hospital 10-year experience with management guidelines for herpes in pregnancy. Aust N Z J Obstet Gynaecol. 1992 Nov;32(4):331–334. doi: 10.1111/j.1479-828x.1992.tb02845.x. [DOI] [PubMed] [Google Scholar]
- Gibbs R. S., Amstey M. S., Lezotte D. C. Role of cesarean delivery in preventing neonatal herpes virus infection. JAMA. 1993 Jul 7;270(1):94–95. [PubMed] [Google Scholar]
- Haddad J., Langer B., Astruc D., Messer J., Lokiec F. Oral acyclovir and recurrent genital herpes during late pregnancy. Obstet Gynecol. 1993 Jul;82(1):102–104. [PubMed] [Google Scholar]
- Harger J. H., Pazin G. J., Breinig M. C. Current understanding of the natural history of genital herpes simplex infections. J Reprod Med. 1986 May;31(5 Suppl):365–373. [PubMed] [Google Scholar]
- Koskiniemi M., Happonen J. M., Järvenpä A. L., Pettay O., Vaheri A. Neonatal herpes simplex virus infection: a report of 43 patients. Pediatr Infect Dis J. 1989 Jan;8(1):30–35. doi: 10.1097/00006454-198901000-00009. [DOI] [PubMed] [Google Scholar]
- Merigan T. C., Gregory D. F., Petralli J. K. Physical properties of human interferon prepared in vitro and in vivo. Virology. 1966 Aug;29(4):515–522. doi: 10.1016/0042-6822(66)90276-5. [DOI] [PubMed] [Google Scholar]
- Randolph A. G., Washington A. E., Prober C. G. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA. 1993 Jul 7;270(1):77–82. [PubMed] [Google Scholar]
- Sacks S. L., Teh C. Z., Lemchuk-Favel L. Serotyping of herpes simplex virus isolates: a comparison of BVDU sensitivities, indirect immunofluorescence with monoclonal antibodies, and indirect immunofluorescence with cross-adsorbed rabbit antibodies. J Virol Methods. 1983 Oct;7(4):199–206. doi: 10.1016/0166-0934(83)90009-5. [DOI] [PubMed] [Google Scholar]
- Vontver L. A., Hickok D. E., Brown Z., Reid L., Corey L. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol. 1982 May 1;143(1):75–84. doi: 10.1016/0002-9378(82)90686-x. [DOI] [PubMed] [Google Scholar]
- Wald A., Corey L., Cone R., Hobson A., Davis G., Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997 Mar 1;99(5):1092–1097. doi: 10.1172/JCI119237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whitley R. J., Nahmias A. J., Soong S. J., Galasso G. G., Fleming C. L., Alford C. A. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. 1980 Oct;66(4):495–501. [PubMed] [Google Scholar]
- Whitley R. J., Nahmias A. J., Visintine A. M., Fleming C. L., Alford C. A. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 1980 Oct;66(4):489–494. [PubMed] [Google Scholar]
- Whitley R., Arvin A., Prober C., Corey L., Burchett S., Plotkin S., Starr S., Jacobs R., Powell D., Nahmias A. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14;324(7):450–454. doi: 10.1056/NEJM199102143240704. [DOI] [PubMed] [Google Scholar]
- van Everdingen J. J., Peeters M. F., ten Have P. Neonatal herpes policy in The Netherlands. Five years after a consensus conference. J Perinat Med. 1993;21(5):371–375. doi: 10.1515/jpme.1993.21.5.371. [DOI] [PubMed] [Google Scholar]